The UK stock market has recently faced challenges, with the FTSE 100 index declining amid weak trade data from China, reflecting broader global economic uncertainties. Despite these headwinds, there are still opportunities for investors interested in smaller or newer companies. Penny stocks, though an older term, continue to offer potential value when backed by strong financial health and growth prospects.
Name
Share Price
Market Cap
Financial Health Rating
Foresight Group Holdings (LSE:FSG)
£4.69
£535.61M
★★★★★★
Warpaint London (AIM:W7L)
£2.16
£174.5M
★★★★★★
Ingenta (AIM:ING)
£0.93
£14.04M
★★★★★★
Northern Bear (AIM:NTBR)
£1.075
£14.79M
★★★★★★
System1 Group (AIM:SYS1)
£2.30
£29.18M
★★★★★★
Integrated Diagnostics Holdings (LSE:IDHC)
$0.56
$325.54M
★★★★★☆
RWS Holdings (AIM:RWS)
£0.723
£267.35M
★★★★★★
Alumasc Group (AIM:ALU)
£2.625
£94.39M
★★★★★★
Begbies Traynor Group (AIM:BEG)
£1.125
£179.55M
★★★★★★
ME Group International (LSE:MEGP)
£1.75
£661.02M
★★★★★★
Click here to see the full list of 296 stocks from our UK Penny Stocks screener.
Here’s a peek at a few of the choices from the screener.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: AOTI, Inc., along with its subsidiaries, focuses on producing, renting, and selling medical devices for treating severe acute and chronic wounds globally, with a market cap of £39.88 million.
Operations: The company’s revenue is primarily generated from the United States, amounting to $63.86 million.
Market Cap: £39.88M
AOTI has recently achieved profitability, reporting a net income of US$0.248 million for the first half of 2025, marking a significant turnaround from a loss the previous year. The company’s revenue increased to US$31.84 million, driven by its medical devices segment. AOTI’s topical oxygen therapy has been recognized by NICE in the UK and included in NHS Supply Chain’s Advanced Wound Care Framework, enhancing its market presence and potential revenue streams. Despite high volatility and negative operating cash flow, AOTI trades below estimated fair value with satisfactory debt levels covered by short-term assets.
AIM:AOTI Financial Position Analysis as at Nov 2025
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Griffin Mining Limited is a mining and investment company focused on the exploration, development, and mining of mineral properties with a market cap of £332.14 million.
Operations: The company generates revenue primarily from its Caijiaying Zinc Gold Mine, which contributed $113.09 million.